期刊文献+

HPLC法测定人血浆中表柔比星的浓度 被引量:5

Determination of Epirubicin in Human Plasma by HPLC
下载PDF
导出
摘要 目的:建立人血浆中表柔比星浓度的测定方法。方法:采用HPLC法测定,色谱柱为Waters XTerra C18(250 mm×4.6 mm,5μm),流动相为乙腈-水(30∶70,pH 2.5),柔红霉素为内标,荧光检测波长为λex=465 nm,λem=550 nm,样品在碱性条件下,用乙酸乙酯液液萃取、浓集后进样。结果:表柔比星在0.02~40μg·ml-1浓度范围内线性关系良好(r=0.999 5,n=12),日内RSD<3.20%,日间RSD<4.71%,方法回收率95.28%~104.62%。结论:该方法简便可靠、专属性好、精密度高,可用于人血浆中表柔比星浓度的测定。 Objective: To establish a method for the determination of epirubicin in human plasma by HPLC.Method: The HPLC method was carried out on a Waters symmtry C18(250 mm×4.6 mm,5 μm)column using acetonitrile-water(30∶ 70,pH 2.5)as the mobile phase,and the detection wavelengths was λex=465 nm and λem=550 nm.The alkalized sample was extracted with ethylacetate1.After evaporation of the organic layer,the residue was dissolved by the mobile phase and determined.Result: The calibration curve of epirubicin was linear over the range of 0.02-40 μg·ml-1(r=0.999 5,n=12).The inter-day precision was less than 3.20% and the intra-day precision was less than 4.71%.The method recovery was 95.28%-104.62%.Conclusion: The method is simple,accurate and reproducible,and it can be used in the determination of epirubicin in human plasma.
出处 《中国药师》 CAS 2012年第10期1456-1457,共2页 China Pharmacist
关键词 表柔比星 高效液相色谱法 血药浓度 Epirubicin HPLC Plasma concentration
  • 相关文献

参考文献4

二级参考文献14

共引文献13

同被引文献27

  • 1赵玉兰,李楠.高效液相色谱法测定血浆中表阿霉素浓度[J].色谱,1995,13(1):49-50. 被引量:5
  • 2魏锋,王进通,顾梅英,林刚,贺能树.反相高效液相色谱法测定阿霉素的血药浓度[J].药物分析杂志,1995,15(3):16-19. 被引量:7
  • 3何剑英.表柔比星与多柔比星治疗老年非霍奇金淋巴瘤对比观察[J].山西职工医学院学报,2005,15(4):41-41. 被引量:5
  • 4.日本抗生物质医药品基准解说[S].[S].,1998.443-445.
  • 5Stoner SC, Pace HA. Asenapine:A clinical re-iew of a second-genera- tion antipsychotic [ J ]. Clinical Therapeutics ,2012,34 ( 5 ) : 1023-1040.
  • 6Kane JM, Cohen M,Zhao J,et al. Efficacy and safety of asenapine in a placebo-and haloperidol-controlled trial in patients with acute exacer- bation of schizophrenia [ J ]. Journal of Clinical Psychopharmacology, 2010,30(2) :106-110.
  • 7Dubo-sky SL, Frobose C, Phiri P, et al. Short-term safety and pharma- cokinetic profile of asenapine in older patients with psychosis [ J ]. In- ternational Journal of Geriatric Psychiatry, 2012,27 (5) :472-482.
  • 8Boer T, Meulman E, Meijcring H, et al. Quantification of asenapine and three metabolites in human plasma using liquid chromatography- tandem mass spectrometry with automated solid-phase extraction: ap- plication to a phase I clinical trial with asenapine in healthy male sub- jeets[ J]. Biomedical Chromatography ,2012,26(2 ) : 156-165.
  • 9日本抗生物质医药品基准解说[S].1993:106.
  • 10严鹏伟.MDR1基因C3435T位点单核苷酸多态性与乳腺癌术后含表柔比星辅助化疗方案的疗效观察和预后因素分析[D].南京:南京医科大学第一临床医学院,2010.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部